Richard Markham

Richard Markham

Plus aucun poste en cours
75 ans
Health Technology
Finance
Consumer Services

Profil

Richard J.
Markham
formerly worked at Aventis Pharma AG, as Chief Executive Officer from 1999 to 2002, Hoechst Marion Roussel, Inc., as Chief Executive Officer, Acura Pharmaceuticals, Inc., as Non-Executive Chairman from 2006 to 2013, Aventis SA, as Vice Chairman & Chief Operating Officer in 2004, Vaxart, Inc., as Chairman, Medpace Research, Inc., as Chairman from 2007 to 2017, Cervelo Pharmaceuticals Ltd., as Chairman, Vaxart, Inc., as Chairman from 2009 to 2019, Sanofi Pasteur, Inc., as Director, CoLucid Pharmaceuticals, Inc., as Independent Director from 2008 to 2015, Marion Merrell Dow, Inc., as President, Chief Operating Officer & Director, Anacor Pharmaceuticals LLC, as Independent Director from 2011 to 2012, Pharmaceutical Research & Manufacturers Association, as Director, Merck & Co., Inc., as President & Chief Operating Officer from 1973 to 1993, Care Capital LLC, as Partner, and HealthCare Institute of New Jersey, as Trustee.
Dr. Markham received his undergraduate degree from Purdue University.

Anciens postes connus de Richard Markham

SociétésPosteFin
Private Equity Investor 08/05/2022
VAXART, INC. Président 30/11/2019
NEPHROGENEX INC Président 28/02/2017
COLUCID PHARMACEUTICALS INC Directeur/Membre du Conseil 27/10/2015
ACURA PHARMACEUTICALS, INC. Président 11/03/2013
Voir l'expérience en détail de Richard Markham

Formation de Richard Markham

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

62

Relations au 1er degré

17

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées17

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Consumer Services

Distribution Services

Health Technology

Pharmaceutical Research & Manufacturers Association

Aventis Pharma AG

Health Technology

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Richard Markham
🔇